Trial Profile
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2015 New trial record